Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
CleanSpark (NASDAQ:CLSK) Shares Gap Up on Analyst Upgrade
CleanSpark, Inc. (NASDAQ:CLSK – Get Free Report) shares gapped up prior to trading on Thursday after Macquarie raised their price...
State Street Corp Trims Stock Position in The Home Depot, Inc. (NYSE:HD)
State Street Corp cut its stake in shares of The Home Depot, Inc. (NYSE:HD – Free Report) by 2.7% during...
ONE Gas (NYSE:OGS) Issues FY 2025 Earnings Guidance
ONE Gas (NYSE:OGS – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance...
Quantinno Capital Management LP Purchases 7,241 Shares of Amgen Inc. (NASDAQ:AMGN)
Quantinno Capital Management LP increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% in the...
Patterson Companies (NASDAQ:PDCO) Stock Rating Upgraded by Mizuho
Mizuho upgraded shares of Patterson Companies (NASDAQ:PDCO – Free Report) to a hold rating in a research note released on...
Barclays Boosts Parker-Hannifin (NYSE:PH) Price Target to $800.00
Parker-Hannifin (NYSE:PH – Get Free Report) had its price objective lifted by research analysts at Barclays from $703.00 to $800.00...